ARTICLE | Distillery Therapeutics
Cancer
March 21, 2017 6:28 PM UTC
Patient sample and cell culture studies suggest inhibiting VAV2 could help treat adrenocortical carcinoma (ACC). In patients, high tumor expression of VAV2 was associated with poor overall survival an...
BCIQ Company Profiles
BCIQ Target Profiles